Arabian Journal for Science and Engineering

, Volume 38, Issue 11, pp 3093–3102 | Cite as

Artificial Pancreas Coupled Vital Signs Monitoring for Improved Patient Safety

  • Salman Hameed Khan
  • Arsalan Hameed Khan
  • Zeashan Hameed Khan
Research Article - Electrical Engineering


This paper describes an improved design of artificial pancreas, which takes into account the physical parameters of human body for detecting hypoglycemic state of diabetic patients. In diabetes mellitus, failure in endogenous insulin production requires exogenous infusion of required drug amount. Traditionally, a closed-loop blood glucose level (BGL) control system includes a patient, continuous glucose monitor, controller and an insulin pump as the actuating device. Such systems are not perfectly safe to use as an overdose due to late action of insulin and/or delay in reading sensor data may lead to dangerously low blood sugar levels (hypoglycemia). Our design incorporates vital signs such as electrocardiogram, heart beat rate, electroencephalography and skin resistance for early detection and avoidance of hypoglycemia state. The objective is to securely control BGL of a patient suffering from diabetes and to prevent the harmful state of hypoglycemia. A typical proportional integrate derivative controller is designed for keeping glucose level inside the desired ‘safe’ range under normal conditions. Once hypoglycemia is detected, a specified amount of glucagon is infused into the patient’s body. The simulations have shown that patient safety can be improved through this strategy. In addition, the model-based design of the purposed system is validated by the UPPAAL model checker tool.


Diabetes Insulin infusion Exogenous Endogenous Feedback control Continuous glucose monitors 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lee, I.; Sokolsky, O.: Medical cyber physical systems. In: Proceedings of DAC, Anaheim, California, USA (2010)Google Scholar
  2. 2.
    High Confidence Software and Systems Coordinating Group. High-confidence medical devices: Cyber-physical systems for 21st century health care. A Research and Development Needs Report, NCO/NITRD, February (2009)Google Scholar
  3. 3.
    World Health Organization. Fact Sheet N 138 (2011). Accessed 16 Aug 2011
  4. 4.
    Diabetes Control and Complications Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329(14): 977–986 (1993)Google Scholar
  5. 5.
    Dua P, Doyle F.J, Pistikopoulos E.N: Model-based blood glucose control for type-1 diabetes via parametric programming. IEEE Trans. Biomed. Eng. 53, 1478–1491 (2006)CrossRefGoogle Scholar
  6. 6.
    Bequette B.W: A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol. Ther. 7(1), 28–47 (2005)CrossRefGoogle Scholar
  7. 7.
    Owens C, Zisser H, Jovanovic L, Srinivasan B, Bonvin D, Doyle J III: Run-to-run control of blood glucose concentrations for people with type-1 diabetes mellitus. IEEE Trans. Biomed. Eng. 53(6), 996–1005 (2006)CrossRefGoogle Scholar
  8. 8.
    Dudde R, Vering T, Piechotta G, Hintsche R: Computer-aided continuous drug infusion: setup and test of a mobile closed-loop system for the continuous automated infusion of insulin. IEEE Trans. Inf. Technol. Biomed. 10(2), 395–402 (2006)CrossRefGoogle Scholar
  9. 9.
    Farmer T.G Jr., Edgar T.F, Peppas N.A: The future of open- and closed-loop insulin delivery systems. J Pharm. Pharmacol. 60(1), 1–13 (2008)CrossRefGoogle Scholar
  10. 10.
    Bellazzi R, Nucci G, Cobelli C: The subcutaneous route to insulin dependent diabetes therapy. IEEE Eng. Med. Biol. 20, 54–64 (2001)CrossRefGoogle Scholar
  11. 11.
    Clarke, E.M.; Emerson, E.A.: Design and synthesis of synchronization skeletons using branching-time temporal logic. In: Workshop on Logic of Programs, pp. 52–71 (1982)Google Scholar
  12. 12.
    Cryer P.E: Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 45(7), 937–48 (2002)Google Scholar
  13. 13.
    Chee, E; Fernando, T.; van Heerden, P.V.: Simulation study on automatic blood glucose control. In: 7th Australian and New Zealand Intelligent Information Systems Conference (2001)Google Scholar
  14. 14.
    Carson, E.R.; Cobelli, C. (eds.) Modelling Methodology for Physiology and Medicine. Academic Press, San Diego (2001)Google Scholar
  15. 15.
    Weinzimer S.A, Steil G.M, Swan K.L, Dziura J, Kurtz N, Tamborlane W.V: Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type-1 diabetes using an artificial pancreas. Diabetes Care. 31(5), 934–939 (2008)CrossRefGoogle Scholar
  16. 16.
    Bergman R.N, Phillips L.S, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and β -cell glucose sensitivity from the response to intravenous glucose. J. Clin. Investig. 68(6), 1456–1467 (1981)Google Scholar
  17. 17.
    Kanoun, K.; Mamaghanian, H.; Khaled, N.; Alonso, D.A.: A real-time compressed sensing-based personal electrocardiogram monitoring system. In: Proceedings of the IEEE/ACM 2011 Design, Automation and Test in Europe Conference (DATE 2011), Grenoble, France, March 14–18 (2011)Google Scholar
  18. 18.
    Chee F, Savkin A.V, Fernando T.L, Nahavandi S: Optimal H∞ insulin injection control for blood glucose regulation in diabetic patients. IEEE Trans. Biomed. Eng. 52(10), 1625–1631 (2005)CrossRefGoogle Scholar
  19. 19.
    Chen, J.; Cao, K.; Sun, Y.; Xiao, Y.; Su, X.: Continuous drug infusion for diabetes therapy: a closed-loop control system design. EURASIP J. Wirel. Commun. Netw. Article ID 495185 (2008)Google Scholar
  20. 20.
    Hovorka R: Continuous glucose monitoring and closed-loop systems. Diabet. Med. 23, 1–12 (2005)CrossRefGoogle Scholar
  21. 21.
    G’omez, E.J.; P’erez, M.E.H.; Vering, T.: The INCA system: a further step towards a telemedical artificial pancreas. IEEE Trans. Inf. Technol. Biomed. 12(4) (2008)Google Scholar
  22. 22.
    Phee, H.K.; Tung, W.L.; Quek, C.: A personalised approach to insulin regulation using brain inspired neural semantic memory in diabetic glucose control. In: IEEE CEC (2007)Google Scholar
  23. 23.
    Borrello, M.A.; Sun, C.A.J.; Bequette, B.W.: A comparison of clinical control strategies for the hyperglycemia of injury and illness. In: American Control Conference (2010)Google Scholar
  24. 24.
    Abu-Khalaf, M., Chen, R., Turevskiy, A.: PID control design made easy. Matlab DigestGoogle Scholar
  25. 25.
    Matlab Simulink R. Documentation. Accessed 5 Sept (2011)
  26. 26.
    Renard E, Costalat G, Chevassus H, Bringer J: Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab. 32(5 Pt 2), 497–502 (2006)CrossRefGoogle Scholar
  27. 27.
    Youssef J.E, Castle J, Ward W.K: A review of closed-loop algorithms for glycemic control in the treatment of type-1 diabetes. Algorithms 2, 518–532 (2009)CrossRefGoogle Scholar
  28. 28.
  29. 29.
    Fang, J.; Tan, S.; Ahmed, B.; Berlian, D.; Cosic, I.: A PDA based ambulatory human skin resistance measuring system. In: Proceedings of the IASTED International Conference on Telehealth, Banff, Canada, 19–21 July (2005)Google Scholar
  30. 30.
    Heller S.R, Macdonald I.A: Physiological disturbances in hypoglycemia: effect on subjective awareness. Clin. Sci. 81, 1–9 (1991)Google Scholar
  31. 31.
    Gale E.A.M, Bennett T, MacDonald I.A, Holst J.J, Matthews J.A: The physiological effects of insulin-induced hypoglycemia in man: responses at differing levels of blood glucose. Clin. Sci. 65, 263–271 (1983)Google Scholar
  32. 32.
    Marques J.L et al.: Altered ventricular repolarisation during hypoglycaemic in patient with diabetes. Diabet. Med. 8, 648–654 (1997)CrossRefGoogle Scholar
  33. 33.
    Nguyen, H.T.; Ghevondian, N.; Jones, T.W.: Real-time detection of nocturnal hypoglycemic episodes using a novel non-invasive hypoglycemia monitor. In: 31st Annual International Conference of the IEEE EMBS (2009)Google Scholar
  34. 34.
    Heger G, Howorka K, Thoma H, Tribl G, Zeitlhofer J: Monitoring set-up for selection of parameters for detection of hypoglycemia in diabetic patients. Med. Biol. Eng. Comput. 34(1), 69–75 (1996)CrossRefGoogle Scholar
  35. 35.
    Koivikko M.L, Salmela P.I et al.: Effects of sustained insulin-induced hypoglycemia on cardiovascular autonomic regulation in type-1 diabetes. Diabetes. 54, 745–750 (2005)CrossRefGoogle Scholar
  36. 36.
    Castle J.R, Engle J.M, Youseff J.E et al.: Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type-1 diabetes. Diabetes Care 33(6), 1282–1287 (2010)CrossRefGoogle Scholar
  37. 37.
    Russo F, Ramponi G: Fuzzy methods for multisensor data fusion. IEEE Trans. Instrum. Meas. 43(2), 288–294 (1994)CrossRefGoogle Scholar
  38. 38.
    Klonoff, D.C.: The artificial pancreas: how sweet engineering will solve bitter problems. J. Diabetes Sci. Technol. 1(1) (2007)Google Scholar

Copyright information

© King Fahd University of Petroleum and Minerals 2012

Authors and Affiliations

  • Salman Hameed Khan
    • 1
  • Arsalan Hameed Khan
    • 2
  • Zeashan Hameed Khan
    • 3
  1. 1.Department of Electrical EngineeringCEME National University of Sciences and Technology (NUST)RawalpindiPakistan
  2. 2.School of AutomationNorthwestern Polytechnical University (NPU)Xi’anChina
  3. 3.Department of Electronics EngineeringCenter for Emerging Sciences, Engineering and Technology (CESET)IslamabadPakistan

Personalised recommendations